Table 3.
Cross-Laboratory Performance Using the UVA Data
| BR | PR | LU | CO | LY | ME | BL | UT | LE | KI | PA | OV | M | CNS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BR | 9 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 12 | 0 | 0 |
| PR | 0 | 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| LU | 0 | 0 | 9 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 0 |
| CO | 0 | 0 | 0 | 22 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| BL | 1 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| KI | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 0 | 0 | 0 | 0 |
| PA | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 0 | 0 | 0 |
| OV | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 17 | 0 | 0 |
BR, breast; PR, prostate; LU, lung; CO, lung; LY, lymphoma; ME, melanoma; BL, bladder; UT, uterus; LE, leukemia; KI, kidney; PA, pancreas; OV, ovary; PM, mesothelioma; CNS, brain. Actual tumor type is designated in the first column and the predicted tumor type designated across the first row.